# Intrathecal Opioids for Pain Control After Cesarean Delivery: Determining the Optimal Dose

> **NCT02009722** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 84 (actual)

## Conditions studied

- Analgesia, Obstetrical
- Cesarean Section

## Interventions

- **DRUG:** Morphine
- **DRUG:** Hydromorphone

## Key facts

- **NCT ID:** NCT02009722
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-12
- **Final completion:** 2015-04
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2016-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02009722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02009722, "Intrathecal Opioids for Pain Control After Cesarean Delivery: Determining the Optimal Dose". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02009722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*